Brand and generic Rx drug spending 2006-2021

This statistic compares total brand prescription medication sales to the sales of branded and unbranded generics in the United States from 2006 to 2021. In 2006, some 216 billion U.S. dollars of brand name medication was sold in the United States. By 2021, this amount increased to some 482 billion dollars.

Brand and generic prescription medication spending in the U.S. from 2006 to 2021 (in billion U.S. dollars)

Characteristic	Brands	Unbranded Generics	Branded Generics
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

April 2022

More information

Region

United States

Survey time period

2006 to 2021

Supplementary notes

Statistic includes non-discounted spending. All figures are rounded and were calculated based on IQVIA data. Includes prescriptions and insulins dispensed by chain and independent pharmacies, food store pharmacies, mail service pharmacies, and long-term care facilities. Spending figures also include sales into hospitals, clinics, and other institutional settings.
Values before 2012 were taken from the GPhA 2010 Annual Report and were not restated.
* Restated.

Citation formats